Search

Search Constraints

You searched for: Author/Creator Imura, Yoshitaka

Search Results

1. A concomitant case of pathologically proven IgG4-related disease and ANCA-associated vasculitis: case report. Issue 1 (2nd January 2018)

2. Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial. (18th February 2022)

3. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies. (7th April 2017)

4. Cell-contact-dependent activation of CD4+ T cells by adhesion molecules on synovial fibroblasts. Issue 3 (4th May 2017)

6. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease. (December 2016)

7. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Issue 4 (15th November 2006)

8. Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis. Issue 3 (27th January 2020)

9. Only rheumatoid factor‐positive subset of anti‐citrullinated peptide/protein antibody‐negative rheumatoid arthritis may seroconvert to anti‐citrullinated peptide/protein antibody‐positive. (15th February 2017)

10. Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody. (February 2017)